A61P 39 - General protective or antinoxious agents

Patents for A61P 39 - General protective or antinoxious agents (19,019)
11/2006
11/08/2006	CN1859922A Medicinal composition
11/08/2006	CN1858229A Process for preparing oligomeric peptide capable of clearing superoxide anion
11/08/2006	CN1858064A Chicken yoke antibody resisting Bengalese cobra venom and its preparation
11/08/2006	CN1857656A Application of plantain herb in preparing medicine and health article with lead removal promoting effect
11/08/2006	CN1857578A Anti-senility health capsule
11/08/2006	CN1857473A Gynostemma pentaphylla saponin composition preparation and its preparing process
11/08/2006	CN1857471A Tribuloside composition preparing and its preparing process
11/08/2006	CN1857470A Preparation and application of shortscape fleabane herb flavonid composition
11/08/2006	CN1857468A Prepn and application of haw heaf total phenolic acid composition
11/08/2006	CN1857443A Preparation and application of astragalus flavonid and total astragalin composition
11/08/2006	CN1857442A Preparation and application of ligustrazine and its salt composition
11/08/2006	CN1857441A Preparation and application of total salvianolic acid composition
11/08/2006	CN1857440A Preparation and application of total paeoniflorin composition
11/08/2006	CN1857439A Preparation and application of ginkgo leaf flavonid composition
11/08/2006	CN1857408A Scullcap stem and leaf injection powder and its preparing method
11/08/2006	CN1857397A Process of extracting flavonid from Haizhou elsholizia as copper polluted soil repairing plant
11/08/2006	CN1857395A Compound Chinese medicine composition for treating cardiac and cerebral vascular diseases
11/08/2006	CN1857387A Preparation and application of pueraria flavonid composition
11/08/2006	CN1857377A Preparation and application of total safflower flavone composition
11/08/2006	CN1857356A Preparation and application of total seabuckthorn flavone composition
11/08/2006	CN1857289A Dispersed compound tablet of glycyrrhizic acid and glycyrrhizinate and its preparing process
11/08/2006	CN1857260A Oral alpha-lipoic acid disintegrant tablet and its preparing method
11/08/2006	CN1857239A Coenzyme Q10 injection emulsion and its preparing process
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/02/2006	WO2006115202A1 Composition for lessening nicotine toxicity
11/02/2006	US20060247293 suppressing death of optic nerve cells during ocular hypertension in patient with glaucoma via administering 3-methyl-1-phenyl-2-pyrazolin-5-one; drops, sustained release formulations
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247228 Phenylazole compounds production process and antioxidants
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	DE202006011650U1 Chitin-, glucan-, melanin product, useful as natural health product for prophylactic, healthy and healing effect, comprises chitin-, glucan-, melanin natural complex produced from fungus of Fomes fomentarius
11/01/2006	CN1853653A Composition containing pearl and vitamine and its use
11/01/2006	CN1853626A Zinc sulfate freeze-dried preparation for injection
10/2006
10/31/2006	US7128900 Light-protection agents
10/31/2006	CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/28/2006	CA2505569A1 Attenuation of disorders by aminoglycosides
10/26/2006	WO2006111833A1 Functional herbal cigarette in controlling body weight and composition
10/26/2006	WO2006111591A1 Method of preparing lycopene-enriched formulations that are free of organic solvents, formulations thus obtained, compositions comprising said formulations and use of same
10/25/2006	EP1714648A1 Combination drug
10/25/2006	EP1713506A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
10/25/2006	EP1713479A1 Nk-1 receptor antagonists anesthesia recovery
10/25/2006	EP1233775B2 Tyrosine- and tryptophan-containing peptides as antioxidants
10/25/2006	CN1850260A Chinese medicine compounded preparation for preventing and treating nickel toxin
10/25/2006	CN1850134A Method for preparing anti-oxygenation composition of oil extrat in guava seeds
10/25/2006	CN1850133A Method for extracting anti-oxygenation active material from Chinese waxmyrtle Bark
10/25/2006	CN1850070A Quercetin solid liposome nano particle preparation and its preparing method
10/25/2006	CN1850065A Use of oral conjugated linoleic acid and its derivative for increasing muscule and skin beauty
10/25/2006	CN1281748C Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
10/25/2006	CN1281267C Chinese medicine medlar-Chinese date preparation for promoting lead expel in high blood lead concentration children and its preparing process
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125884 N-but-3-enyl norbuprenorphine and its use as analgesic
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	CA2227711C Thioctic acid metabolites and methods of use thereof
10/19/2006	WO2006108595A1 Use of sporopollenin and/or the derivatives thereof as a component of medicaments, medical products, and food supplements
10/19/2006	US20060235239 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
10/19/2006	US20060233729 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners
10/18/2006	EP1712225A1 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists
10/18/2006	EP1711195A1 Process for preparation of extract of decalepis hamiltonii having antioxidant activity
10/18/2006	EP1212070B1 Plant extract mixtures (cissus, vernonia, brillantaisia) and their uses
10/18/2006	CN1849287A Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal
10/18/2006	CN1846695A Application of 3,5,7,3',4',5'-hexahydroxyl-2,3-dihydroflavone in preparing medicine
10/18/2006	CN1279972C Purified cytokine inhibitory factor
10/18/2006	CN1279920C Slow release preparation of diammonium glycyrrhizate
10/17/2006	US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases
10/12/2006	WO2006107626A1 Desferrithiocin polyether analogues
10/12/2006	DE102005016714A1 Verwendung von Sporopollenin und/oder deren Derivaten als Bestandteil von Arzneimitteln, Medizinalprodukten und Nahrungsergänzungsmitteln Use of Sporopollenin and / or their derivatives as part of medicines medical products and food supplements
10/12/2006	CA2603385A1 Desferrithiocin polyether analogues and uses thereof for treating metal overload, oxidative stress, and neoplastic and preneoplastic conditions
10/11/2006	EP1399150A4 Vitamin c compositions
10/11/2006	EP1154792B1 Tuberculosis vaccine formulation comprising monoglycerides or fatty acids as adjuvant
10/11/2006	CN1844130A Maple extract and its use in preparation of free radical scavenger or antioxidant
10/11/2006	CN1843222A Vinegar beverage and preparation method thereof
10/11/2006	CN1278682C Nanometer preparation of natural vitamin E
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006	US7119087 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
10/10/2006	CA2321909C Product and method to reduce stress induced immune suppression
10/10/2006	CA2255951C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
10/05/2006	WO2006104402A1 Copper antagonist compositions
10/05/2006	WO2006104397A1 Copper antagonist compositions
10/05/2006	WO2006104154A1 Composition for enhancing expression and activity of protease in liver
10/05/2006	WO2006104153A1 Composition for increasing anti-oxidation activity in blood
10/05/2006	WO2006103316A1 Food composition for binding acetaldehyde in mouth and in digestive track, and method for the preparation of the composition
10/05/2006	US20060223769 Vaccines using nucleic acid-lipid complexes
10/05/2006	CA2610854A1 Nicotinamide riboside and analogues thereof
10/04/2006	EP1706415A1 Lipid- derivatized bisphosphonic acid
10/04/2006	EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide
10/04/2006	EP1507527A4 Methods for enhancing motor performance and/or endurance
10/04/2006	CN1842341A Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng
10/04/2006	CN1840659A Method of treating endotoxemia
10/04/2006	CN1840637A Mild wine with aloe as main traditional-Chinese-drug raw material and its production method and use
10/04/2006	CN1840143A Composite preparation for resisting oxidation, preventing and treating senile dementia and preparation method thereof
10/04/2006	CN1839995A High mountain gadol capsule
10/04/2006	CN1839887A Spider freeze-drying powder preparation method and its uses in medicine and health product
10/04/2006	CN1839830A Chinese medicinal preparation of sedum extract and preparation process thereof
10/04/2006	CN1839809A Novel uses of (E) -4,4íõ-dimethoxy styrene and its composition containing same
09/2006
09/28/2006	WO2006101106A1 Precious metal nanocolloid solution
09/28/2006	WO2006067330B1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides
09/28/2006	US20060217445 Natural astaxanthin extract reduces dna oxidation
09/27/2006	EP1704865A2 Treatment of C. difficile toxin B associated conditions
09/27/2006	EP1704855A2 2-Cyclopenten-1-one and its Derivatives as Inhibitors of the NF-kappa B Factor
09/27/2006	EP1703913A2 Use of ribose in recovery from anaesthesia
09/27/2006	EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators

1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 191